Package 59676-575-30

{"route": ["ORAL"], "spl_id": "afe12b96-bf92-4c0a-8cd1-cdd8677b7d32", "openfda": {}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (59676-575-30)", "package_ndc": "59676-575-30", "marketing_start_date": "20150131"}], "brand_name": "PREZCOBIX", "product_id": "59676-575_afe12b96-bf92-4c0a-8cd1-cdd8677b7d32", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitor [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "HIV Protease Inhibitors [MoA]", "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Protease Inhibitor [EPC]"], "product_ndc": "59676-575", "generic_name": "DARUNAVIR ETHANOLATE and COBICISTAT", "labeler_name": "Janssen Products, LP", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PREZCOBIX", "active_ingredients": [{"name": "COBICISTAT", "strength": "150 mg/1"}, {"name": "DARUNAVIR ETHANOLATE", "strength": "800 mg/1"}], "application_number": "NDA205395", "marketing_category": "NDA", "marketing_start_date": "20150131", "listing_expiration_date": "20271231"}